Shingles shot’s value is uncertain

The cost-effectiveness of a new vaccine against shingles remains uncertain, according to a new study. So, health policy makers don’t have enough information to recommend for or against routine use of the shot, say the researchers.

Shingles, also called herpes zoster, develops when a person previously infected with chickenpox experiences a reactivation of the dormant virus.